Emerging approaches for preventing cytokine release syndrome in CAR-T cell therapy.
Journal Information
Full Title: J Mater Chem B
Abbreviation: J Mater Chem B
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Nanotechnology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflicts of interest Dr Ishihara is a co-founder and shareholder of ArrowImmune Inc., which develops anti-cancer immunotherapies. The other authors declare no conflicts of interest."
"This work was in part supported by Imperial College London's internal funding (to J. I.). We thank Cancer Research UK (to J. I.) and the Academy of Medical Sciences (to J. I.). K. S. was supported by JSPS Overseas Research Fellowships (202160429). Fig. 1, 6, 9 and 11 were made with BioRender.com."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025